Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

  • Read more about Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

  • Read more about Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities

  • Read more about Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

  • Read more about A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

Yale COVID-19 Recovery Study

  • Read more about Yale COVID-19 Recovery Study

Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)

  • Read more about Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)

Defibrotide for the Treatment of Severe COVID-19

  • Read more about Defibrotide for the Treatment of Severe COVID-19

Cognitive Rehabilitation Therapy for COVID-19

  • Read more about Cognitive Rehabilitation Therapy for COVID-19

Immvira Pharma Co. Ltd

By jpalfreyman on Fri, 03/29/2024 - 09:50
  • Read more about Immvira Pharma Co. Ltd

Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

  • Read more about Antimicrobial Resistance During the SARS-CoV-2 (COVID-19) Pandemic

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 136
  • Page 137
  • Page 138
  • Page 139
  • Current page 140
  • Page 141
  • Page 142
  • Page 143
  • Page 144
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA